Remove Clinical Development Remove International Remove Trials
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialisation, and at Georgetown Law School as an adjunct professor.

article thumbnail

LEO partners with ICON to offer patient-centric dermatology trials

Drug Discovery World

LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The partnership will operate under the acronym of PACE, reflecting the requirement to move quickly to address today’s clinical development challenges.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patients show 91% response to allogeneic CAR-T therapy

Drug Discovery World

The interim data from an ongoing Phase I trial in patients who have previously received three or more prior lines of therapy were presented at the 21 st International Myeloma Society (IMS) Annual Meeting in Rio de Janeiro. Arm C was identified as the optimised lymphodepletion arm based on cellular kinetics, safety and efficacy.

Therapies 147
article thumbnail

Drug’s unique mechanism of action targets schizophrenia abnormalities

Drug Discovery World

Evenamide could have blockbuster potential A new placebo controlled, one-year trial in patients with TRS who are receiving other antipsychotics is currently in the planning stages with with Dr Marder as the Principal Investigator.

article thumbnail

‘Off-the-shelf’ CAR-T secures FDA advanced therapy designation

Drug Discovery World

P-BCMA-ALLO1 is an investigational stem cell memory T cell (TSCM)-based allogeneic CAR-T cell therapy in Phase I/Ib clinical development for the treatment of patients with relapsed/refractory multiple myeloma.

Therapies 130
article thumbnail

Sponsored content: Overcoming the blocks to successful clinical trials

Drug Discovery World

Dominic Elliston , Managing Director of Evoke Galliard and Evoke Incisive Health, shares his take on how effective clinical trial communications is the key to expediting the delivery of new and extraordinary treatments. What’s that got to do with clinical trials? Tell us about yourself, Dominic.

article thumbnail

What can patients do to give input into clinical trial design? 

Drug Discovery World

We are hopefully nearing the tail-end of a pandemic that made the whole world become participants in that deep learning experience of what clinical development is. I think never before did we have families sit on the couch and talk about Phase I, II and III clinical trials. appeared first on Drug Discovery World (DDW).